LEXICON PHARMACEUTICALS, INC. Weighted Average Number of Shares Issued, Basic
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Weighted Average Number of Shares Issued, Basic of 165.73 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2023-03-03
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for the quarter ending 2019-12-31 was 106.27M shares.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for the quarter ending 2019-09-30 was 106.27M shares.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for the quarter ending 2019-06-30 was 106.27M shares.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for the quarter ending 2019-03-31 was 106.05M shares.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for fiscal 2022 was 165.73M shares, a 13.79% increase from fiscal 2021.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for fiscal 2021 was 145.65M shares, a 31.41% increase from fiscal 2020.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for fiscal 2020 was 110.84M shares, a 4.35% increase from fiscal 2019.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares issued, basic for fiscal 2019 was 106.22M shares, a 0.37% increase from fiscal 2018.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 12 month |
|---|---|---|
| 2022-12-31 | 165.73M shares 10-K · filed 2023-03-03 | |
| 2021-12-31 | 145.65M shares 10-K · filed 2023-03-03 | |
| 2020-12-31 | 110.84M shares 10-K · filed 2023-03-03 | |
| 2019-12-31 | 106.27M shares 10-K · filed 2020-03-12 | 106.22M shares 10-K · filed 2022-03-10 |
| 2019-09-30 | 106.27M shares 10-K · filed 2020-03-12 | |
| 2019-06-30 | 106.27M shares 10-K · filed 2020-03-12 | |
| 2019-03-31 | 106.05M shares 10-K · filed 2020-03-12 | |
| 2018-12-31 | 105.83M shares 10-K · filed 2021-03-12 | |
| 2017-12-31 | 105.24M shares 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |